We’re excited to announce the MEF2C Foundation Australia’s first fundraiser!

We’re raising money to further research into MEF2C related conditions and pathways to therapeutic treatments.

Together with the other global MEF2C organisations, we have recently attended a US Food and Drug Administration (FDA) Patient Listening Session (PLS) organised by our friends at the MEF2C Foundation (UK) and Rarebird (US).